$Soluna(SLNH.US) just filed a document showing that a retail investor has become a major shareholder, now holding 6.6% of the shares. Robert Duggan is a well-known figure in the biopharmaceutical and investment sectors (former CEO of Pharmacyclics). Although such big players usually have their own family offices or investment institutions, this 13G filing clearly indicates that these shares are held directly or beneficially in his personal name.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
